메뉴 건너뛰기




Volumn 9, Issue , 2016, Pages 6549-6559

Cell-free DNA as a diagnostic marker for cancer: Current insights

Author keywords

Cancer; Cell free DNA; Diagnosis; Liquid biopsy

Indexed keywords

CELL FREE DNA; DNA; UNCLASSIFIED DRUG;

EID: 84993967978     PISSN: None     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S100901     Document Type: Review
Times cited : (101)

References (95)
  • 2
    • 84990062718 scopus 로고    scopus 로고
    • A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC cohort. Clin Cancer Res
    • Terry KL, Schock H, Fortner RT, et al. A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC cohort. Clin Cancer Res. Epub 2016 Apr 8.
    • (2016) Epub , pp. 8
    • Terry, K.L.1    Schock, H.2    Fortner, R.T.3
  • 3
    • 84940655696 scopus 로고    scopus 로고
    • Tumor markers CA19-9, CA242 and CEA in the diagnosis of pancreatic cancer: A meta-analysis
    • Zhang Y, Yang J, Li H, Wu Y, Zhang H, Chen W. Tumor markers CA19-9, CA242 and CEA in the diagnosis of pancreatic cancer: a meta-analysis. Int J Clin Exp Med. 2015;8(7):11683–11691.
    • (2015) Int J Clin Exp Med , vol.8 , Issue.7 , pp. 11683-11691
    • Zhang, Y.1    Yang, J.2    Li, H.3    Wu, Y.4    Zhang, H.5    Chen, W.6
  • 4
    • 0037351819 scopus 로고    scopus 로고
    • Clinical Sciences Reviews Committee of the Association of Clinical Biochemists. Cell-free nucleic acids in plasma, serum and urine: A new tool in molecular diagnosis
    • Chan AK, Chiu RW, Lo YM; Clinical Sciences Reviews Committee of the Association of Clinical Biochemists. Cell-free nucleic acids in plasma, serum and urine: a new tool in molecular diagnosis. Ann Clin Biochem. 2003;40(Pt 2):122–130.
    • (2003) Ann Clin Biochem , vol.40 , pp. 122-130
    • Chan, A.K.1    Chiu, R.W.2    Lo, Y.M.3
  • 5
    • 84959105405 scopus 로고    scopus 로고
    • Cell-free circulating tumour DNA as a liquid biopsy in breast cancer
    • De Mattos-Arruda L, Caldas C. Cell-free circulating tumour DNA as a liquid biopsy in breast cancer. Mol Oncol. 2016;10(3): 464–474.
    • (2016) Mol Oncol , vol.10 , Issue.3 , pp. 464-474
    • De Mattos-Arruda, L.1    Caldas, C.2
  • 6
    • 84957852098 scopus 로고
    • Les acides nucleiques du plasma sanguin chez l’ homme [The nucleic acids in blood plasma in humans
    • Mandel P, Metais P. Les acides nucleiques du plasma sanguin chez l’ homme [The nucleic acids in blood plasma in humans]. C R Seances Soc Biol Fil. 1948;142(3–4):241–243.
    • (1948) C R Seances Soc Biol Fil , vol.142 , Issue.34 , pp. 241-243
    • Mandel, P.1    Metais, P.2
  • 7
    • 0024420298 scopus 로고
    • Neoplastic characteristics of the DNA found in the plasma of cancer patients
    • Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C, Beljanski M. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology. 1989;46(5):318–322.
    • (1989) Oncology , vol.46 , Issue.5 , pp. 318-322
    • Stroun, M.1    Anker, P.2    Maurice, P.3    Lyautey, J.4    Lederrey, C.5    Beljanski, M.6
  • 8
    • 0034327356 scopus 로고    scopus 로고
    • Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids
    • Goessl C, Krause H, Müller M, et al. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. Cancer Res. 2000;60(21):5941–5945.
    • (2000) Cancer Res , vol.60 , Issue.21 , pp. 5941-5945
    • Goessl, C.1    Krause, H.2    Müller, M.3
  • 9
    • 84940095522 scopus 로고    scopus 로고
    • Serial next-generation sequencing of circulating cell-free DNA evaluating tumor clone response to molecularly targeted drug administration
    • Frenel JS, Carreira S, Goodall J, et al. Serial next-generation sequencing of circulating cell-free DNA evaluating tumor clone response to molecularly targeted drug administration. Clin Cancer Res. 2015;21(20): 4586–4596.
    • (2015) Clin Cancer Res , vol.21 , Issue.20 , pp. 4586-4596
    • Frenel, J.S.1    Carreira, S.2    Goodall, J.3
  • 10
    • 84886249189 scopus 로고    scopus 로고
    • Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: Preliminary data
    • Casadio V, Calistri D, Tebaldi M, et al. Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data. Urol Oncol. 2013;31(8):1744–1750.
    • (2013) Urol Oncol , vol.31 , Issue.8 , pp. 1744-1750
    • Casadio, V.1    Calistri, D.2    Tebaldi, M.3
  • 11
    • 84908672066 scopus 로고    scopus 로고
    • Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer
    • Hao TB, Shi W, Shen XJ, et al. Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer. Br J Cancer. 2014;111(8):1482–1489.
    • (2014) Br J Cancer , vol.111 , Issue.8 , pp. 1482-1489
    • Hao, T.B.1    Shi, W.2    Shen, X.J.3
  • 12
    • 84952719744 scopus 로고    scopus 로고
    • Assessment of DNA integrity, applications for cancer research
    • Zonta E, Nizard P, Taly V. Assessment of DNA integrity, applications for cancer research. Adv Clin Chem. 2015;70:197–246.
    • (2015) Adv Clin Chem , vol.70 , Issue.197 , pp. 246
    • Zonta, E.1    Nizard, P.2    Taly, V.3
  • 13
    • 84920508228 scopus 로고    scopus 로고
    • Circulating tumor DNA as a liquid biopsy for cancer
    • Heitzer E, Ulz P, Geigl JB. Circulating tumor DNA as a liquid biopsy for cancer. Clin Chem. 2015;61(1):112–123.
    • (2015) Clin Chem , vol.61 , Issue.1 , pp. 112-123
    • Heitzer, E.1    Ulz, P.2    Geigl, J.B.3
  • 14
    • 78650207098 scopus 로고    scopus 로고
    • Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus
    • Lo YM, Chan KC, Sun H, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med. 2010;2(61):61ra91.
    • (2010) Sci Transl Med. , vol.2 , Issue.61
    • Lo, Y.M.1    Chan, K.C.2    Sun, H.3
  • 15
    • 77949395254 scopus 로고    scopus 로고
    • Medicine. Keeping tabs on tumor DNA
    • Kaiser J. Medicine. Keeping tabs on tumor DNA. Science. 2010; 327(5969):1074.
    • (2010) Science , vol.327 , Issue.5969 , pp. 1074
    • Kaiser, J.1
  • 16
    • 84877806778 scopus 로고    scopus 로고
    • Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer
    • Heitzer E, Auer M, Hoffmann EM, et al. Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer. Int J Cancer. 2013;133(2):346–356.
    • (2013) Int J Cancer , vol.133 , Issue.2 , pp. 346-356
    • Heitzer, E.1    Auer, M.2    Hoffmann, E.M.3
  • 17
    • 0642311916 scopus 로고    scopus 로고
    • Quantification of free circulating DNA as a diagnostic marker in lung cancer
    • Sozzi G, Conte D, Leon M, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol. 2003;21(21): 3902–3908.
    • (2003) J Clin Oncol , vol.21 , Issue.21 , pp. 3902-3908
    • Sozzi, G.1    Conte, D.2    Leon, M.3
  • 18
    • 84905036017 scopus 로고    scopus 로고
    • Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: Diagnostic validity and significant reduction of cfDNA after surgical resection
    • Kim K, Shin DG, Park MK, et al. Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection. Ann Surg Treat Res. 2014;86(3):136–142.
    • (2014) Ann Surg Treat Res , vol.86 , Issue.3 , pp. 136-142
    • Kim, K.1    Shin, D.G.2    Park, M.K.3
  • 19
    • 84944746986 scopus 로고    scopus 로고
    • Quantitative analysis of cell-free DNA in ovarian cancer
    • Shao X, He Y, Ji M, et al. Quantitative analysis of cell-free DNA in ovarian cancer. Oncol Lett. 2015;10(6):3478–3482.
    • (2015) Oncol Lett , vol.10 , Issue.6 , pp. 3478-3482
    • Shao, X.1    He, Y.2    Ji, M.3
  • 20
    • 0019201556 scopus 로고
    • Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus
    • Raptis L, Menard HA. Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J Clin Invest. 1980;66(6):1391–1399.
    • (1980) J Clin Invest , vol.66 , Issue.6 , pp. 1391-1399
    • Raptis, L.1    Menard, H.A.2
  • 21
    • 0020581141 scopus 로고
    • Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease
    • Shapiro B, Chakrabarty M, Cohn EM, Leon SA. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer. 1983;51(11):2116–2120.
    • (1983) Cancer , vol.51 , Issue.11 , pp. 2116-2120
    • Shapiro, B.1    Chakrabarty, M.2    Cohn, E.M.3    Leon, S.A.4
  • 22
    • 84938418410 scopus 로고    scopus 로고
    • Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease
    • Szpechcinski A, Chorostowska-Wynimko J, Struniawski R, et al. Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease. Br J Cancer. 2015;113(3):476–483.
    • (2015) Br J Cancer , vol.113 , Issue.3 , pp. 476-483
    • Szpechcinski, A.1    Chorostowska-Wynimko, J.2    Struniawski, R.3
  • 23
    • 0035103448 scopus 로고    scopus 로고
    • Quantitation of genomic DNA in plasma and serum samples: Higher concentrations of genomic DNA found in serum than in plasma
    • Lee TH, Montalvo L, Chrebtow V, Busch MP. Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma. Transfusion. 2001;41(2): 276–282.
    • (2001) Transfusion , vol.41 , Issue.2 , pp. 276-282
    • Lee, T.H.1    Montalvo, L.2    Chrebtow, V.3    Busch, M.P.4
  • 24
    • 16244367487 scopus 로고    scopus 로고
    • Effects of preanalytical factors on the molecular size of cell-free DNA in blood
    • Chan KCA, Yeung S-W, Lui W-B, Rainer TH, Lo YMD. Effects of preanalytical factors on the molecular size of cell-free DNA in blood. Clin Chem. 2005;51(4):781–784.
    • (2005) Clin Chem , vol.51 , Issue.4 , pp. 781-784
    • Chan, K.1    Yeung, S.-W.2    Lui, W.-B.3    Rainer, T.H.4    Lo, Y.5
  • 25
    • 33845476677 scopus 로고    scopus 로고
    • Circulating nucleic acids (CNAs) and cancer – a survey
    • Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer – a survey. Biochim Biophys Acta. 2007;1775(1):181–232.
    • (2007) Biochim Biophys Acta , vol.1775 , Issue.1 , pp. 181-232
    • Fleischhacker, M.1    Schmidt, B.2
  • 26
    • 84921758615 scopus 로고    scopus 로고
    • Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer
    • Rothé F, Laes J-F, Lambrechts D, et al. Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer. Ann Oncol. 2014;25(10):1959–1965.
    • (2014) Ann Oncol , vol.25 , Issue.10 , pp. 1959-1965
    • Rothé, F.1    Laes, J.-F.2    Lambrechts, D.3
  • 27
    • 84926416450 scopus 로고    scopus 로고
    • Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types
    • Lebofsky R, Decraene C, Bernard V, et al. Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types. Mol Oncol. 2015;9(4):783–790.
    • (2015) Mol Oncol , vol.9 , Issue.4 , pp. 783-790
    • Lebofsky, R.1    Decraene, C.2    Bernard, V.3
  • 28
    • 84923081743 scopus 로고    scopus 로고
    • Circulating tumor DNA: New horizons for improving cancer treatment
    • Lianos GD, Mangano A, Cho WC, Dionigi G, Roukos DH. Circulating tumor DNA: new horizons for improving cancer treatment. Future Oncol. 2015;11(4):545–548.
    • (2015) Future Oncol , vol.11 , Issue.4 , pp. 545-548
    • Lianos, G.D.1    Mangano, A.2    Cho, W.C.3    Dionigi, G.4    Roukos, D.H.5
  • 29
    • 84896371874 scopus 로고    scopus 로고
    • Detection of circulating tumor DNA in early- and late-stage human malignancies
    • Bettegowda C, Sausen M, Leary RJ, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6(224):224ra24.
    • (2014) Sci Transl Med , vol.6 , Issue.224
    • Bettegowda, C.1    Sausen, M.2    Leary, R.J.3
  • 30
    • 84903218109 scopus 로고    scopus 로고
    • An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
    • Newman AM, Bratman SV, To J, et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat Med. 2014;20(5):548–554.
    • (2014) Nat Med , vol.20 , Issue.5 , pp. 548-554
    • Newman, A.M.1    Bratman, S.V.2
  • 31
    • 84942519785 scopus 로고    scopus 로고
    • Diagnostic accuracy of noninvasive genotyping of EGFR in lung cancer patients by deep sequencing of plasma cell-free DNA
    • Uchida J, Kato K, Kukita Y, et al. Diagnostic accuracy of noninvasive genotyping of EGFR in lung cancer patients by deep sequencing of plasma cell-free DNA. Clin Chem. 2015;61(9):1191–1196.
    • (2015) Clin Chem , vol.61 , Issue.9 , pp. 1191-1196
    • Uchida, J.1    Kato, K.2    Kukita, Y.3
  • 32
    • 79954431896 scopus 로고    scopus 로고
    • Detection of HER2 amplification in circulating free DNA in patients with breast cancer
    • Page K, Hava N, Ward B, et al. Detection of HER2 amplification in circulating free DNA in patients with breast cancer. Br J Cancer. 2011; 104(8):1342–1348.
    • (2011) Br J Cancer , vol.104 , Issue.8 , pp. 1342-1348
    • Page, K.1    Hava, N.2    Ward, B.3
  • 33
    • 84945925969 scopus 로고    scopus 로고
    • Detection of clonal and subclonal copy-number variants in cell-free DNA from patients with breast cancer using a massively multiplexed PCR methodology
    • Kirkizlar E, Zimmermann B, Constantin T, et al. Detection of clonal and subclonal copy-number variants in cell-free DNA from patients with breast cancer using a massively multiplexed PCR methodology. Transl Oncol. 2015;8(5):407–416.
    • (2015) Transl Oncol , vol.8 , Issue.5 , pp. 407-416
    • Kirkizlar, E.1    Zimmermann, B.2    Constantin, T.3
  • 34
    • 35348906194 scopus 로고    scopus 로고
    • Measurement of cyclin E genomic copy number and strand length in cell-free DNA distinguish malignant versus benign effusions
    • Salani R, Davidson B, Fiegl M, et al. Measurement of cyclin E genomic copy number and strand length in cell-free DNA distinguish malignant versus benign effusions. Clin Cancer Res. 2007;13(19): 5805–5809.
    • (2007) Clin Cancer Res , vol.13 , Issue.19 , pp. 5805-5809
    • Salani, R.1    Davidson, B.2    Fiegl, M.3
  • 35
    • 84905686383 scopus 로고    scopus 로고
    • Microsatellite instability typing in serum and tissue of patients with colorectal cancer: Comparing real time PCR with hybridization probe and high-performance liquid chromatography
    • Mokarram P, Rismanchi M, Alizadeh Naeeni M, et al. Microsatellite instability typing in serum and tissue of patients with colorectal cancer: comparing real time PCR with hybridization probe and high-performance liquid chromatography. Mol Biol Rep. 2014;41(5):2835–2844.
    • (2014) Mol Biol Rep , vol.41 , Issue.5 , pp. 2835-2844
    • Mokarram, P.1    Rismanchi, M.2    Alizadeh Naeeni, M.3
  • 36
    • 3242668700 scopus 로고    scopus 로고
    • Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer
    • Schwarzenbach H, Müller V, Stahmann N, Pantel K. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer. Ann N Y Acad Sci. 2004;1022:25–32.
    • (2004) Ann N Y Acad Sci , vol.1022 , Issue.25 , pp. 32
    • Schwarzenbach, H.1    Müller, V.2    Stahmann, N.3    Pantel, K.4
  • 37
    • 0035875037 scopus 로고    scopus 로고
    • Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients
    • Sozzi G, Conte D, Mariani L, et al. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res. 2001;61(12):4675–4678.
    • (2001) Cancer Res , vol.61 , Issue.12 , pp. 4675-4678
    • Sozzi, G.1    Conte, D.2    Mariani, L.3
  • 38
    • 0037146259 scopus 로고    scopus 로고
    • Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer
    • Chang HW, Lee SM, Goodman SN, et al. Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer. J Natl Cancer Inst. 2002;94(22):1697–1703.
    • (2002) J Natl Cancer Inst , vol.94 , Issue.22 , pp. 1697-1703
    • Chang, H.W.1    Lee, S.M.2    Goodman, S.N.3
  • 39
    • 84903692972 scopus 로고    scopus 로고
    • Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis
    • Madhavan D, Wallwiener M, Bents K, et al. Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis. Breast Cancer Res Treat. 2014;146(1):163–174.
    • (2014) Breast Cancer Res Treat , vol.146 , Issue.1 , pp. 163-174
    • Madhavan, D.1    Wallwiener, M.2    Bents, K.3
  • 40
    • 33748045808 scopus 로고    scopus 로고
    • DNA integrity assay: A plasma-based screening tool for the detection of prostate cancer
    • Hanley R, Rieger-Christ KM, Canes D, et al. DNA integrity assay: a plasma-based screening tool for the detection of prostate cancer. Clin Cancer Res. 2006;12(15):4569–4574.
    • (2006) Clin Cancer Res , vol.12 , Issue.15 , pp. 4569-4574
    • Hanley, R.1    Rieger-Christ, K.M.2    Canes, D.3
  • 41
    • 0033050166 scopus 로고    scopus 로고
    • K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: Diagnostic utility and prognostic significance
    • Castells A, Puig P, Móra J, et al. K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance. J Clin Oncol. 1999;17(2):578–584.
    • (1999) J Clin Oncol , vol.17 , Issue.2 , pp. 578-584
    • Castells, A.1    Puig, P.2    Móra, J.3
  • 42
    • 0036829637 scopus 로고    scopus 로고
    • A prospective study of detection of pancreatic carcinoma by combined plasma K-ras mutations and serum CA19-9 analysis
    • Dianxu F, Shengdao Z, Tianquan H, et al. A prospective study of detection of pancreatic carcinoma by combined plasma K-ras mutations and serum CA19-9 analysis. Pancreas. 2002;25(4):336–341.
    • (2002) Pancreas , vol.25 , Issue.4 , pp. 336-341
    • Dianxu, F.1    Shengdao, Z.2    Tianquan, H.3
  • 43
    • 84927615702 scopus 로고    scopus 로고
    • Circulating free DNA as biomarker and source for mutation detection in metastatic colorectal cancer
    • Spindler KLG, Pallisgaard N, Andersen RF, Brandslund I, Jakobsen A. Circulating free DNA as biomarker and source for mutation detection in metastatic colorectal cancer. PLoS One. 2015;10(4):1–14.
    • (2015) Plos One , vol.10 , Issue.4 , pp. 1-14
    • Spindler, K.1    Pallisgaard, N.2    Andersen, R.F.3    Brandslund, I.4    Jakobsen, A.5
  • 44
    • 84903549166 scopus 로고    scopus 로고
    • Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer
    • Mouliere F, El Messaoudi S, Pang D, Dritschilo A, Thierry AR. Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer. Mol Oncol. 2014;8(5):927–941.
    • (2014) Mol Oncol , vol.8 , Issue.5 , pp. 927-941
    • Mouliere, F.1    El Messaoudi, S.2    Pang, D.3    Dritschilo, A.4    Thierry, A.R.5
  • 45
    • 34247537858 scopus 로고    scopus 로고
    • Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy
    • Shinozaki M, O’Day SJ, Kitago M, et al. Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy. Clin Cancer Res. 2007;13(7):2068–2074.
    • (2007) Clin Cancer Res , vol.13 , Issue.7 , pp. 2068-2074
    • Shinozaki, M.1    O’Day, S.J.2    Kitago, M.3
  • 46
    • 2642531973 scopus 로고    scopus 로고
    • Epigenetics in human disease and prospects for epigenetic therapy
    • Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429(6990): 457–463.
    • (2004) Nature , vol.429 , Issue.6990 , pp. 457-463
    • Egger, G.1    Liang, G.2    Aparicio, A.3    Jones, P.A.4
  • 47
    • 33749024160 scopus 로고    scopus 로고
    • Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer
    • Hoque MO, Feng Q, Toure P, et al. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. J Clin Oncol. 2006;24(26):4262–4269.
    • (2006) J Clin Oncol , vol.24 , Issue.26 , pp. 4262-4269
    • Hoque, M.O.1    Feng, Q.2    Toure, P.3
  • 48
    • 84903196176 scopus 로고    scopus 로고
    • Differential promoter methylation of kinesin family member 1a in plasma is associated with breast cancer and DNA repair capacity
    • Guerrero-Preston R, Hadar T, Ostrow KL, et al. Differential promoter methylation of kinesin family member 1a in plasma is associated with breast cancer and DNA repair capacity. Oncol Rep. 2014;32(2): 505–512.
    • (2014) Oncol Rep , vol.32 , Issue.2 , pp. 505-512
    • Guerrero-Preston, R.1    Hadar, T.2    Ostrow, K.L.3
  • 49
    • 84878225964 scopus 로고    scopus 로고
    • Detection of serum Alu element hypom-ethylation for the diagnosis and prognosis of glioma
    • Chen J, Gong M, Lu S, et al. Detection of serum Alu element hypom-ethylation for the diagnosis and prognosis of glioma. J Mol Neurosci. 2013;50(2):368–375.
    • (2013) J Mol Neurosci , vol.50 , Issue.2 , pp. 368-375
    • Chen, J.1    Gong, M.2    Lu, S.3
  • 50
    • 79959686697 scopus 로고    scopus 로고
    • Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: A meta-analysis
    • Wu T, Giovannucci E, Welge J, Mallick P, Tang WY, Ho SM. Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis. Br J Cancer. 2011;105(1):65–73.
    • (2011) Br J Cancer , vol.105 , Issue.1 , pp. 65-73
    • Wu, T.1    Giovannucci, E.2    Welge, J.3    Mallick, P.4    Tang, W.Y.5    Ho, S.M.6
  • 51
    • 84899886835 scopus 로고    scopus 로고
    • Prostate cancer molecular detection in plasma samples by glutathione S-transferase P1 (GSTP1) methylation analysis
    • Dumache R, Puiu M, Motoc M, Vernic C, Dumitrascu V. Prostate cancer molecular detection in plasma samples by glutathione S-transferase P1 (GSTP1) methylation analysis. Clin Lab. 2014;60(5):847–852.
    • (2014) Clin Lab , vol.60 , Issue.5 , pp. 847-852
    • Dumache, R.1    Puiu, M.2    Motoc, M.3    Vernic, C.4    Dumitrascu, V.5
  • 53
    • 84891743167 scopus 로고    scopus 로고
    • Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer
    • Church TR, Wandell M, Lofton-Day C, et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut. 2014;63(2):317–325.
    • (2014) Gut , vol.63 , Issue.2 , pp. 317-325
    • Church, T.R.1    Wandell, M.2    Lofton-Day, C.3
  • 54
    • 84898816773 scopus 로고    scopus 로고
    • Septin 9 promoter region methylation in free circulating DNA-potential role in noninvasive diagnosis of lung cancer: Preliminary report
    • Powrózek T, Krawczyk P, Kucharczyk T, Milanowski J. Septin 9 promoter region methylation in free circulating DNA-potential role in noninvasive diagnosis of lung cancer: preliminary report. Med Oncol. 2014;31(4):917.
    • (2014) Med Oncol , vol.31 , Issue.4 , pp. 917
    • Powrózek, T.1    Krawczyk, P.2    Kucharczyk, T.3    Milanowski, J.4
  • 55
    • 33646847495 scopus 로고    scopus 로고
    • Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation
    • Skvortsova TE, Rykova EY, Tamkovich SN, et al. Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation. Br J Cancer. 2006; 94(10):1492–1495.
    • (2006) Br J Cancer , vol.94 , Issue.10 , pp. 1492-1495
    • Skvortsova, T.E.1    Rykova, E.Y.2    Tamkovich, S.N.3
  • 56
    • 84863229057 scopus 로고    scopus 로고
    • DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps
    • Cassinotti E, Melson J, Liggett T, et al. DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps. Int J Cancer. 2012;131(5):1153–1157.
    • (2012) Int J Cancer , vol.131 , Issue.5 , pp. 1153-1157
    • Cassinotti, E.1    Melson, J.2    Liggett, T.3
  • 57
    • 83855162906 scopus 로고    scopus 로고
    • Serum cell-free DNA in renal cell carcinoma: A diagnostic and prognostic marker
    • de Martino M, Klatte T, Haitel A, Marberger M. Serum cell-free DNA in renal cell carcinoma: a diagnostic and prognostic marker. Cancer. 2012;118(1):82–90.
    • (2012) Cancer , vol.118 , Issue.1 , pp. 82-90
    • De Martino, M.1    Klatte, T.2    Haitel, A.3    Marberger, M.4
  • 58
    • 4644271551 scopus 로고    scopus 로고
    • Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients
    • Ibanez de Caceres I, Battagli C, Esteller M, et al. Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients. Cancer Res. 2004;64(18): 6476–6481.
    • (2004) Cancer Res , vol.64 , Issue.18 , pp. 6476-6481
    • Ibanez De Caceres, I.1    Battagli, C.2    Esteller, M.3
  • 60
    • 58849140824 scopus 로고    scopus 로고
    • Differential methylation profile of ovarian cancer in tissues and plasma
    • Melnikov A, Scholtens D, Godwin A, Levenson V. Differential methylation profile of ovarian cancer in tissues and plasma. J Mol Diagn. 2009; 11(1):60–65.
    • (2009) J Mol Diagn , vol.11 , Issue.1 , pp. 60-65
    • Melnikov, A.1    Scholtens, D.2    Godwin, A.3    Levenson, V.4
  • 61
    • 78649907173 scopus 로고    scopus 로고
    • Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors
    • Liggett TE, Melnikov A, Yi Q, et al. Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors. Gynecol Oncol. 2011;120(1):113–120.
    • (2011) Gynecol Oncol , vol.120 , Issue.1 , pp. 113-120
    • Liggett, T.E.1    Melnikov, A.2    Yi, Q.3
  • 62
    • 84864359164 scopus 로고    scopus 로고
    • Preliminary study analyzing the methylated genes in the plasma of patients with pancreatic cancer
    • Park JW, Baek IH, Kim YT. Preliminary study analyzing the methylated genes in the plasma of patients with pancreatic cancer. Scand J Surg. 2012;101(1):38–44.
    • (2012) Scand J Surg , vol.101 , Issue.1 , pp. 38-44
    • Park, J.W.1    Baek, I.H.2    Kim, Y.T.3
  • 63
    • 85039764762 scopus 로고    scopus 로고
    • Methylation of cell-free circulating DNA in the diagnosis of cancer
    • Warton K, Samimi G. Methylation of cell-free circulating DNA in the diagnosis of cancer. Front Mol Biosci. 2015;2:13.
    • (2015) Front Mol Biosci , vol.2 , Issue.13
    • Warton, K.1    Samimi, G.2
  • 64
    • 84884153858 scopus 로고    scopus 로고
    • Hypermethylation of tumor suppressor genes in serum as potential biomarker for the diagnosis of nasopharyngeal carcinoma
    • Tian F, Yip SP, Kwong DL, Lin Z, Yang Z, Wu V. Promoter hypermethylation of tumor suppressor genes in serum as potential biomarker for the diagnosis of nasopharyngeal carcinoma. Cancer Epidemiol. 2013; 37(5):708–713.
    • (2013) Cancer Epidemiol , vol.37 , Issue.5 , pp. 708-713
    • Tian, F.1    Yip, S.P.2    Kwong, D.L.3    Lin, Z.4    Yang, Z.5    Promoter, W.V.6
  • 65
    • 84856721943 scopus 로고    scopus 로고
    • DNA methylation changes correlate with Gleason score and tumor stage in prostate cancer
    • Delgado-Cruzata L, Hruby GW, Gonzalez K, et al. DNA methylation changes correlate with Gleason score and tumor stage in prostate cancer. DNA Cell Biol. 2012;31(2):187–192.
    • (2012) DNA Cell Biol , vol.31 , Issue.2 , pp. 187-192
    • Delgado-Cruzata, L.1    Hruby, G.W.2    Gonzalez, K.3
  • 66
    • 84872598584 scopus 로고    scopus 로고
    • Usefulness of plasma epigenetic changes of five major genes involved in the pathogenesis of colorectal cancer
    • Pack SC, Kim HR, Lim SW, et al. Usefulness of plasma epigenetic changes of five major genes involved in the pathogenesis of colorectal cancer. Int J Colorectal Dis. 2013;28(1):139–147.
    • (2013) Int J Colorectal Dis , vol.28 , Issue.1 , pp. 139-147
    • Pack, S.C.1    Kim, H.R.2    Lim, S.W.3
  • 67
    • 36749012555 scopus 로고    scopus 로고
    • Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer
    • Ellinger J, El Kassem N, Heukamp LC, et al. Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer. J Urol. 2008;179(1):346–352.
    • (2008) J Urol , vol.179 , Issue.1 , pp. 346-352
    • Ellinger, J.1    El Kassem, N.2    Heukamp, L.C.3
  • 68
    • 79551513940 scopus 로고    scopus 로고
    • Hypermethylation of tumor suppressor genes involved in critical regulatory pathways for developing a blood-based test in breast cancer
    • Radpour R, Barekati Z, Kohler C, et al. Hypermethylation of tumor suppressor genes involved in critical regulatory pathways for developing a blood-based test in breast cancer. PLoS One. 2011;6(1):e16080.
    • (2011) Plos One , vol.6 , Issue.1
    • Radpour, R.1    Barekati, Z.2    Kohler, C.3
  • 69
    • 80052967970 scopus 로고    scopus 로고
    • SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma
    • Kneip C, Schmidt B, Seegebarth A, et al. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma. J Thorac Oncol. 2011;6(10):1632–1638.
    • (2011) J Thorac Oncol , vol.6 , Issue.10 , pp. 1632-1638
    • Kneip, C.1    Schmidt, B.2    Seegebarth, A.3
  • 70
    • 84870326702 scopus 로고    scopus 로고
    • Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer
    • Lange CP, Campan M, Hinoue T, et al. Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer. PLoS One. 2012;7(11):e50266.
    • (2012) Plos One , vol.7 , Issue.11
    • Lange, C.P.1    Campan, M.2    Hinoue, T.3
  • 71
    • 84862862840 scopus 로고    scopus 로고
    • Urinary biomarkers of non-muscle-invasive bladder cancer: Current status and future potential
    • Calistri D, Casadio V, Bravaccini S, Zoli W, Amadori D. Urinary biomarkers of non-muscle-invasive bladder cancer: current status and future potential. Expert Rev Anticancer Ther. 2012;12(6):743–752.
    • (2012) Expert Rev Anticancer Ther , vol.12 , Issue.6 , pp. 743-752
    • Calistri, D.1    Casadio, V.2    Bravaccini, S.3    Zoli, W.4    Amadori, D.5
  • 72
    • 13844274979 scopus 로고    scopus 로고
    • Detection of bladder cancer using a point-of-care proteomic assay
    • Grossman HB, Messing E, Soloway M, et al. Detection of bladder cancer using a point-of-care proteomic assay. JAMA. 2005;293(7):810–816.
    • (2005) JAMA , vol.293 , Issue.7 , pp. 810-816
    • Grossman, H.B.1    Messing, E.2    Soloway, M.3
  • 73
    • 84916237853 scopus 로고    scopus 로고
    • Can urinary PCA3 supplement PSA in the early detection of prostate cancer?
    • Wei JT, Feng Z, Partin AW, et al. Can urinary PCA3 supplement PSA in the early detection of prostate cancer? J Clin Oncol. 2014;32(36): 4066–4072.
    • (2014) J Clin Oncol , vol.32 , Issue.36 , pp. 4066-4072
    • Wei, J.T.1    Feng, Z.2    Partin, A.W.3
  • 74
    • 0033870263 scopus 로고    scopus 로고
    • Genetic analysis of DNA excreted in urine: A new approach for detecting specific genomic DNA sequences from cells dying in an organism
    • Botezatu I, Serdyuk O, Potapova G, et al. Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin Chem. 2000;46(8 Pt 1):1078–1084.
    • (2000) Clin Chem , vol.46 , Issue.8 , pp. 1078-1084
    • Botezatu, I.1    Serdyuk, O.2    Potapova, G.3
  • 75
    • 2342642789 scopus 로고    scopus 로고
    • Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer
    • Su YH, Wang M, Brenner DE, et al. Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer. J Mol Diagn. 2004;6(2):101–107.
    • (2004) J Mol Diagn , vol.6 , Issue.2 , pp. 101-107
    • Su, Y.H.1    Wang, M.2    Brenner, D.E.3
  • 76
    • 39049186213 scopus 로고    scopus 로고
    • Detection of a K-ras mutation in urine of patients with colorectal cancer
    • Su YH, Wang M, Aiamkitsumrit B, Brenner DE, Block TM. Detection of a K-ras mutation in urine of patients with colorectal cancer. Cancer Biomark. 2005;1(2–3):177–182.
    • (2005) Cancer Biomark , vol.1 , Issue.23 , pp. 177-182
    • Yh, S.1    Wang, M.2    Aiamkitsumrit, B.3    Brenner, D.E.4    Block, T.M.5
  • 77
    • 52249107130 scopus 로고    scopus 로고
    • Detection of mutated K-ras DNA in urine, plasma, and serum of patients with colorectal carcinoma or adenomatous polyps
    • Su YH, Wang M, Brenner DE, Norton PA, Block TM. Detection of mutated K-ras DNA in urine, plasma, and serum of patients with colorectal carcinoma or adenomatous polyps. Ann N Y Acad Sci. 2008;1137:197–206.
    • (2008) Ann N Y Acad Sci , vol.1137 , Issue.197 , pp. 206
    • Yh, S.1    Wang, M.2    Brenner, D.E.3    Norton, P.A.4    Block, T.M.5
  • 79
    • 70449345868 scopus 로고    scopus 로고
    • Evaluation of cell-free DNA in urine as a marker for bladder cancer diagnosis
    • Zancan M, Galdi F, Di Tonno F, et al. Evaluation of cell-free DNA in urine as a marker for bladder cancer diagnosis. Int J Biol Markers. 2009;24(3):147–155.
    • (2009) Int J Biol Markers , vol.24 , Issue.3 , pp. 147-155
    • Zancan, M.1    Galdi, F.2    Di Tonno, F.3
  • 80
    • 34548535845 scopus 로고    scopus 로고
    • Deletion analysis of tumor and urinary DNA to detect bladder cancer: Urine supernatant versus urine sediment
    • Szarvas T, Kovalszky I, Bedi K, et al. Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment. Oncol Rep. 2007;18(2):405–409.
    • (2007) Oncol Rep , vol.18 , Issue.2 , pp. 405-409
    • Szarvas, T.1    Kovalszky, I.2    Bedi, K.3
  • 81
    • 84874826585 scopus 로고    scopus 로고
    • Urine cell-free DNA integrity as a marker for early prostate cancer diagnosis: A pilot study
    • Casadio V, Calistri D, Salvi S, et al. Urine cell-free DNA integrity as a marker for early prostate cancer diagnosis: a pilot study. Biomed Res Int. 2013;2013:270457.
    • (2013) Biomed Res Int , pp. 2013
    • Casadio, V.1    Calistri, D.2    Salvi, S.3
  • 82
    • 84941039754 scopus 로고    scopus 로고
    • Urine cell-free DNA integrity analysis for early detection of prostate cancer patients
    • Salvi S, Gurioli G, Martignano F, et al. Urine cell-free DNA integrity analysis for early detection of prostate cancer patients. Dis Markers. 2015;2015:574120.
    • (2015) Dis Markers , pp. 2015
    • Salvi, S.1    Gurioli, G.2    Martignano, F.3
  • 83
    • 84955259942 scopus 로고    scopus 로고
    • Genomic alterations in liquid biopsies from patients with bladder cancer
    • Birkenkamp-Demtröder K, Nordentoft I, Christensen E, et al. Genomic alterations in liquid biopsies from patients with bladder cancer. Eur Urol. 2016;70(1):75–82.
    • (2016) Eur Urol , vol.70 , Issue.1 , pp. 75-82
    • Birkenkamp-Demtröder, K.1    Nordentoft, I.2    Christensen, E.3
  • 84
    • 84954349604 scopus 로고    scopus 로고
    • Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA
    • Togneri FS, Ward DG, Foster JM, et al. Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA. Eur J Hum Genet. 2016;24(8):1167–1174.
    • (2016) Eur J Hum Genet , vol.24 , Issue.8 , pp. 1167-1174
    • Togneri, F.S.1    Ward, D.G.2    Foster, J.M.3
  • 85
    • 84978062670 scopus 로고    scopus 로고
    • Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer. Oncotarget
    • Xia Y, Huang CC, Dittmar R, et al. Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer. Oncotarget. Epub 2016 Apr 26.
    • (2016) Epub , pp. 26
    • Xia, Y.1    Huang, C.C.2    Dittmar, R.3
  • 86
    • 52249118141 scopus 로고    scopus 로고
    • Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients
    • Bryzgunova OE, Morozkin ES, Yarmoschuk SV, Vlassov VV, Laktionov PP. Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients. Ann N Y Acad Sci. 2008;1137: 222–225.
    • (2008) Ann N Y Acad Sci , vol.1137 , pp. 222-225
    • Bryzgunova, O.E.1    Morozkin, E.S.2    Yarmoschuk, S.V.3    Vlassov, V.V.4    Laktionov, P.P.5
  • 87
    • 33645284007 scopus 로고    scopus 로고
    • Methylation of endogenous human retroelements in health and disease
    • Schulz WA, Steinhoff C, Florl AR. Methylation of endogenous human retroelements in health and disease. Curr Top Microbiol Immunol. 2006;310:211–250.
    • (2006) Curr Top Microbiol Immunol , vol.310 , pp. 211-250
    • Schulz, W.A.1    Steinhoff, C.2    Florl, A.R.3
  • 88
    • 84938685598 scopus 로고    scopus 로고
    • Unreserved application of epigenetic methods to define differences of DNA methylation between urinary cellular and cell-free DNA
    • Ghanjati F, Beermann A, Hermanns T, et al. Unreserved application of epigenetic methods to define differences of DNA methylation between urinary cellular and cell-free DNA. Cancer Biomark. 2014;14(5): 295–302.
    • (2014) Cancer Biomark , vol.14 , Issue.5 , pp. 295-302
    • Ghanjati, F.1    Beermann, A.2    Hermanns, T.3
  • 89
    • 84863115484 scopus 로고    scopus 로고
    • Detection of hypermethylated vimen-tin in urine of patients with colorectal cancer
    • Song BP, Jain S, Lin SY, et al. Detection of hypermethylated vimen-tin in urine of patients with colorectal cancer. J Mol Diagn. 2012; 14(2):112–119.
    • (2012) J Mol Diagn , vol.14 , Issue.2 , pp. 112-119
    • Song, B.P.1    Jain, S.2    Lin, S.Y.3
  • 90
    • 34250855800 scopus 로고    scopus 로고
    • Promoter hypermethylation of tumor suppressor genes in urine from patients with cervical neoplasia
    • Feng Q, Hawes SE, Stern JE, et al. Promoter hypermethylation of tumor suppressor genes in urine from patients with cervical neoplasia. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1178–1184.
    • (2007) Cancer Epidemiol Biomarkers Prev , vol.16 , Issue.6 , pp. 1178-1184
    • Feng, Q.1    Hawes, S.E.2    Stern, J.E.3
  • 91
    • 79957458567 scopus 로고    scopus 로고
    • Cell-free nucleic acids as biomarkers in cancer patients
    • Schwarzenbach H, Hoon DSB, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11(6):426–437.
    • (2011) Nat Rev Cancer , vol.11 , Issue.6 , pp. 426-437
    • Schwarzenbach, H.1    Hoon, D.2    Pantel, K.3
  • 92
    • 61349121505 scopus 로고    scopus 로고
    • Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer
    • Schwarzenbach H, Alix-Panabières C, Müller I, et al. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer. Clin Cancer Res. 2009;15(3):1032–1038.
    • (2009) Clin Cancer Res , vol.15 , Issue.3 , pp. 1032-1038
    • Schwarzenbach, H.1    Alix-Panabières, C.2    Müller, I.3
  • 93
    • 84948669109 scopus 로고    scopus 로고
    • STARD 2015: An updated list of essential items for reporting diagnostic accuracy studies
    • Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Clin Chem. 2015;61(12):1446–1452.
    • (2015) Clin Chem , vol.61 , Issue.12 , pp. 1446-1452
    • Bossuyt, P.M.1    Reitsma, J.B.2    Bruns, D.E.3
  • 94
    • 84941551429 scopus 로고    scopus 로고
    • Predicting radiotherapy responses and treatment outcomes through analysis of circulating tumor DNA
    • Chaudhuri AA, Binkley MS, Osmundson EC, Alizadeh AA, Diehn M. Predicting radiotherapy responses and treatment outcomes through analysis of circulating tumor DNA. Semin Radiat Oncol. 2015;25(4): 305–312.
    • (2015) Semin Radiat Oncol , vol.25 , Issue.4 , pp. 305-312
    • Chaudhuri, A.A.1    Binkley, M.S.2    Osmundson, E.C.3    Alizadeh, A.A.4    Diehn, M.5
  • 95
    • 84947286516 scopus 로고    scopus 로고
    • Circulating tumor cells and circulating tumor DNA: Challenges and opportunities on the path to clinical utility
    • Ignatiadis M, Lee M, Jeffrey SS. Circulating tumor cells and circulating tumor DNA: challenges and opportunities on the path to clinical utility. Clin Cancer Res. 2015;21(21):4786–4800.
    • (2015) Clin Cancer Res , vol.21 , Issue.21 , pp. 4786-4800
    • Ignatiadis, M.1    Lee, M.2    Jeffrey, S.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.